• 제목/요약/키워드: Cholangiocarcinoma

검색결과 225건 처리시간 0.025초

Preemptive pyloroplasty for iatrogenic vagus nerve injury in intrahepatic cholangiocarcinoma patients undergoing extensive left-sided lymph node dissection: a retrospective observational study

  • Hwang, Shin;Jung, Dong-Hwan;Jwa, Eun-Kyoung;Kim, Yumi
    • Journal of Yeungnam Medical Science
    • /
    • 제39권3호
    • /
    • pp.235-243
    • /
    • 2022
  • Background: Intrahepatic cholangiocarcinoma (ICC) of the left liver often shows left-sided lymph node (LN) metastasis. If gastric lesser curvature is extensively dissected, it can induce an iatrogenic injury to the extragastric vagus nerve branches that control motility of the pyloric sphincter and lead to gastric stasis. To cope with such LN dissection-associated gastric stasis, we performed pyloroplasty preemptively. The objective of this study was to analyze our 20-year experience of preemptive pyloroplasty performed in 10 patients. Methods: We investigated clinical sequences of 10 patients with ICC who underwent preemptive pyloroplasty following left hepatectomy and extended left-sided LN dissection. Incidence of gastric stasis and oncological survival outcomes were analyzed. Results: All 10 patients were classified as stage IIIB due to T1-3N1M0 stage according to the 8th edition of American Joint Committee on Cancer staging system. The overall patient survival rate was 51.9% at 1 year, 25.9% at 2 years, and 0% at 3 years. Seven patients showed uneventful postoperative recovery after surgery. Two patients suffered from gastric stasis, which was successfully managed with supportive care. One patient suffered from overt gastric paresis, which was successfully managed with azithromycin administration for 1 month. Conclusion: We believe that preemptive pyloroplasty is an effective surgical option to prevent gastric stasis in patients undergoing extensive left-sided LN dissection. Azithromycin appears to be a potent prokinetic agent in gastroparesis.

Biliary Obstruction Caused by Non-Hodgkin Lymphoma Involvement: A Case Report

  • Jae Hyun Lim;Huapyong Kang;Jung Hyun Jo;Hee Seung Lee;Jeong Youp Park;Seungmin Bang;Seung Woo Park;Si Young Song;Moon Jae Chung
    • Journal of Digestive Cancer Research
    • /
    • 제6권1호
    • /
    • pp.32-35
    • /
    • 2018
  • Non-Hodgkin's lymphoma is known to be a rare and unusual cause of biliary obstruction. We report a case of biliary obstruction that a 25-year-old male showed icteric sclera and yellow discoloration of his skin caused by metastasis of non-Hodgkin lymphoma. Initial imaging & endoscopic work-up led us to an impression of either cholangiocarcinoma or IgG4-related disease, yet the pathological results weren't diagnostic. Through our thorough re-examination, we found a 5cm sized round, fixed, non-tender sternal mass, and additional imaging studies were suggestive of lymphoma, which was also consistent with the results of incisional chest wall biopsy. Biliary obstruction by lymphoma was successfully treated by endoscopic plastic stent insertion procedure and chemotherapy. Although it is widely accepted that lymphoma accounts for very few portion of malignant biliary obstruction, due to the fact that lymphoma and cholangiocarcinoma are often indistinguishable, careful diagnostic approach should be done.

  • PDF

원발성 간세포암의 비특이적 영상 소견 및 간암으로 오인될 수 있는 병변에 대한 영상의학적 고찰 (Atypical Manifestation of Primary Hepatocellular Carcinoma and Hepatic Malignancy Mimicking Lesions)

  • 윤지영;박소현;안수좌;심영섭
    • 대한영상의학회지
    • /
    • 제83권4호
    • /
    • pp.808-829
    • /
    • 2022
  • 간세포암종은 역동적 조영증강 컴퓨터단층촬영이나 자기공명영상에서의 동맥기 조영증강 및 문맥기 또는 지연기 씻김현상과 같은 전형적 영상 소견을 기반으로 비침습적으로 진단할 수 있다. 그러나 일부 간세포암종은 비전형적인 영상 소견을 나타내기 때문에 영상의학과 의사는 진단에 있어 어려움에 직면하게 된다. 더욱이 동맥 문맥 단락, 혼합 간세포-담관암, 간내 담관암, 혈관종과 같이 많은 간세포암 유사 병변들이 다수 존재하여 영상을 통한 감별 진단에 난항을 겪는다. 초기 영상 검사에서 간세포암종과 이러한 유사 종양을 구별하는 능력은 적절한 관리 및 치료 결정에 중요하다. 따라서 본 임상화보에서는 간세포암종의 비전형적 영상 소견과 간세포암종을 모방하는 악성 및 양성 병변들의 영상 소견을 제시하고 감별 진단을 좁히는 데 도움이 될 수 있는 중요한 단서들에 대해 알아보고자 한다.

Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999-2019

  • Sung Yeon Hong;Mee Joo Kang;Taegyu Kim;Kyu-Won Jung;Bong-Wan Kim
    • 한국간담췌외과학회지
    • /
    • 제26권3호
    • /
    • pp.211-219
    • /
    • 2022
  • Backgrounds/Aims: Historically, incidence and survival analysis and annual traits for primary liver cancer (LC) has not been investigated in a population-based study in Korea. The purpose of the current study is to determine incidence, survival rate of patients with primary LC in Korea. Methods: We conducted a retrospective cohort study using Korea Central Cancer Registry based on the Korea National Cancer Incidence Database. Statistical analysis including crude rate and age-standadized rate (ASR) of incidence and mortality was performed for LC patients registered with C22 code in International Classification of Diseases, tenth revision from 1999 to 2019. Subgroup analysis was performed for hepatocellular carcinoma (HCC, C22.0) and intrahepatic cholangiocarcinoma (IHCC, C22.1). Results: The crude incidence rate of HCC (21.0 to 22.8 per 100,000) and IHCC (2.3 to 5.6 per 100,000) increased in the observed period from 1999 to 2019. The ASR decreased in HCC (20.7 to 11.9 per 100,000) but remained unchanged in IHCC (2.4 to 2.7 per 100,000). The proportion of HCC patients diagnosed in early stages (localized or regional Surveillance, Epidemiology, and End Results or SEER stage) increased significantly over time. As expected, 5-yeat survival rate of HCC was greatly improved, reaching 42.4% in the period between 2013 and 2019. This trait was more prominent in localized SEER stage. On the other hand, the proportion of IHCC patients diagnosed in localized stage remained unchanged (22.9% between 2013 and 2019), although ASR and 5-year survival rate showed minor improvements. Conclusions: A great improvement in survival rate was observed in patients with newly diagnosed HCCs. It was estimated to be due to an increase in early detection rate. On the contrary, detection rate of an early IHCC was stagnant with a minor improvement in prognosis.

재발한 간담도암 환자에서 시행 한 high-dose-rate intraluminal brachytherapy의 유용성 및 재현성 평가 (Availability and Reproducibility Evaluation of High-dose-rate Intraluminal Brachytherapy for Unresectable Recurrent Cholangiocarcinoma)

  • 박주경;이승훈;차석용;김양수;이선영
    • 한국방사선학회논문지
    • /
    • 제6권2호
    • /
    • pp.151-157
    • /
    • 2012
  • 간담도암의 일차적 치료법은 수술적 제거이나, 초기 병기로 수술을 하여도 재발이 흔하며, 재발 후에는 근치적 목적이 아닌 주로 증상 완화 목적의 치료를 하고 있다. 이에 본 연구에서는 재발한 환자에서 자체 도입한 특수 관을 이용한 근치적 목적의 high-dose-rate intraluminal brachytherapy의 치료법과 치료 set-up 재현성 유지에 대하여 고찰하고 자 한다. 본 연구는 간담도암으로 수술 후, 6개월 간격으로 복부 자기 공명 영상을 이용한 추적 검사를 시행하여, 수술문합 부위의 재발이 확인된 임상 병기 rcT1N0M0인 환자를 대상으로 하였다. 근접 치료를 위하여 경피적 담도 배액관을 치료 전용관인 Arrow Sheath로 교체 후, intraluminal catheter를 삽입하여, 일회 치료당 3 Gy 씩 총 30 Gy 근접치료를 시행하였다. 협착 된 담도의 distal and proximal 그리고 central axis point로부터 1 cm 떨어진 지점을 선량표준화였으며, 5회에 걸쳐 치료 전 dummy seed 삽입 후, 치료 표적 용적 근위부와 말단부의 기준점에서 흉추 사이의 거리를 측정하여 set-up 재현성을 평가하였다. 매주 치료 전 근위부와 말단부위 치료 표적 용적 기준점에서 흉추 사이의 거리를 5회 측정한 값과 simulation image에서 측정된 거리를 비교한 결과 평균값과 표준편차가 오차율 5% 이내로 유의한 수준으로 측정되어 매회 치료시 재현성이 유지 되었다, 본 연구 환자의 추적 검사 상 1년 이상 무병 생존하고 있으며, 심각한 부작용 또한 관찰되지 않았다. 따라서, 수술이 불가능한 재발한 간담도암 환자에서 본원에서 자체 도입한 관으로 시행한 근접치료는 주변 인접 장기의 심각한 부작용 발생 없이, 매 회 치료 시 재현성이 유의한 수준으로 유지 되는 것으로 평가되었다.

담관암의 위치와 형태에 따른 $^{18}$F-FDG 섭취량의 차이와 임상적 의의 (Different $^{18}$F-FDG Uptake According to Tumor location and Morphology of Cholangiocarcinoma and Its Clinical Implication)

  • 이원석;이윤재;임석태;손명희;이승옥
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제43권4호
    • /
    • pp.317-322
    • /
    • 2009
  • 목적: 담관암의 진단과 치료 평가를 위해서 여러 영상학적 방법이 이용되나 성장 형태를 포함한 질환의 성상이 아주 다양하고 종양과 주변 조직간의 대조도가 낮은 경우 발견이 어렵고 주로 종양 부분에 대한 국소 영상을 시행하여 질병의 전신 평가에는 충분하지 못할 수 있다. 이러한 점을 보완하기 위하여 $^{18}$F-FDG PET에 대한 연구가 이루어 지고 있는데, 본 연구에서는 담관암의 발생위치와 성장형태에 따라 $^{18}$F-FDG 섭취양상의 변화와 그에 따른 임상적 의의를 알아보고자 하였다. 대상 및 방법: 2005년 4월부터 2008년 5월까지 담관암으로 진단 받고 PET/CT를 촬영한 환자를 대상으로 하였다. 위치에 따른 담관암의 분류는 간내담관암과 간외담관암으로 나누고 간외담관암은 간문부암과 원위부 담도 암으로 나누었다. 간외담관암은 다시 그 성장형태에 따라 경화형, 결절형, 용종형으로 분류하여 PET양성인 환자들 중 SUV$_{max}$를 비교하였다. 결과: 총 82명의 담도암 환자들 중PET양성을 보인 환자는 81.7%이었다. PET 양성을 보인 간내담관암 환자는 23명으로 이들의 SUV$_{max}$는 9.4$\pm$4.1로 간외담관암보다 의미있게 높았다. 용종형의 간외담관암은 9명중 모두가 PET 양성이었고, SUV$_{max}$도 10.1$\pm$7.0으로 경화형, 결절형에 비해 높았다. 결론: 본 연구의 결과를 바탕으로$^{18}$F-FDG PET은 간외담관암보다는 간내담관암을 가진 환자의 진단에 더 유용할 것으로 보이며, 간외담관암의 진단에 있어서는 담도벽을 따라 침윤성으로 발생하는 경화형보다는 종괴를 형성하는 용종형에서 더 의미있는 검사방법이 될 수 있겠다.

F-18 FDG PET/CT로 재구성한 담관암의 3차원 영상 (Three Dimensional Volume Rendering Fusion Images Using F-18 FDG PET/CT in Evaluation of Cholangiocellular Carcinoma)

  • 공은정;조인호;천경아;원규장;이형우;은종열
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권1호
    • /
    • pp.81-81
    • /
    • 2008
  • A 69-year old male with cholangiocellular carcinoma (CCC) was assigned to our department for whole body PET/CT scan. $^{18}F$-FDG PET/CT images showed an intense hypermetabolic lobulating mass(SUVmax = 8.7 / size : 11.4 mm) in the right hepatic lobe with multiple metastatic lung nodules. We made three dimensional volume rendering fusion images by using advantage workstation 4.3 (GE health care) which provide quick anatomic overview and improve the planning process significantly.

Isocitrate dehydrogenase mutations: new opportunities for translational research

  • Keum, Young-Sam;Choi, Bu Young
    • BMB Reports
    • /
    • 제48권5호
    • /
    • pp.266-270
    • /
    • 2015
  • Over the last decade, comprehensive genome-wide sequencing studies have enabled us to find out unexpected genetic alterations of metabolism in cancer. An example is the identification of arginine missense mutations of isocitrate dehydrogenases-1 and -2 (IDH1/2) in glioma, acute myeloid leukemia (AML), chondrosarcomas, and cholangiocarcinoma. These alterations are closely associated with the production of a new stereospecific metabolite, (R)-2-hydroxyglutarate (R-2HG). A large number of follow-up studies have been performed to address the molecular mechanisms of IDH1/2 mutations underlying how these events contribute to malignant transformation. In the meanwhile, the development of selective mutant IDH1/2 chemical inhibitors is being actively pursued in the scientific community and pharmaceutical industry. The present review article briefly discusses the important findings that highlight the molecular mechanisms of IDH1/2 mutations in cancer and provides a current status for development of selective mutant IDH1/2 chemical inhibitors. [BMB Reports 2015; 48(5): 266-270]

보중익기탕 투여 후 화학항암제로 인한 전신쇠약감 및 탈모호전 증례보고 (A Case Report of Chemotherapy-induced Alopecia Treated with Bojungikki-tang)

  • 이상헌
    • 대한한방내과학회지
    • /
    • 제38권2호
    • /
    • pp.235-239
    • /
    • 2017
  • This case study describes the effect of Bojungikki-tang on chemotherapy-induced alopecia. Alopecia is a well-documented cause of distress to patients undergoing cancer treatment, but no approved pharmacological treatment exists for chemotherapy-induced hair loss. A 70-year-old female diagnosed with a cholangiocarcinoma and liver metastasis received chemotherapy, including gemcitabine and cisplatin, every three weeks. As a result of the continuous chemotherapy, she suffered various toxicity-related side effects, including bone marrow suppression, general weakness, nausea, peripheral numbness, and hair loss. Bojungikki-tang was initially administered to improve the patient's general weakness and fatigue. After three months of treatment, the patient's hair loss and general condition improved, and the color of the new hair was dark, despite the chemotherapy. The treatment did not improve other symptoms, such as bone marrow suppression and peripheral numbness. This case suggests that Bojungikki-tang could have a beneficial effect on chemotherapy-induced alopecia.

Imaging diagnosis of clonorchiasis

  • Choi, Don-Gil;Hong, Sung-Tae
    • Parasites, Hosts and Diseases
    • /
    • 제45권2호
    • /
    • pp.77-85
    • /
    • 2007
  • Among several diagnostic tools for clonorchiasis (Clonorchis sinensis infection), radiologic examinations are commonly used in clinical practices. During the 2 past decades, many reports regarding imaging findings of clonorchiasis were introduced. The basic imaging finding of clonorchiasis is diffuse dilatation of the peripheral intra-hepatic bile ducts, without dilation of the large intrahepatic or extrahepatic bile ducts. By this finding, however, active clonorchiasis cannot be differentiated from cured infection. Some recent radiologic studies suggested specific findings of active clonorchiasis. Besides direct demonstration of worms, increased periductal echogenicity on sonography and periductal enhancement on dynamic contrast-enhanced CT or MR imaging possibly represent active clonorchiasis. Those images of the liver clonorchiasis are known to be correlated with worm burdens (EPG counts) in their frequency and also severity. The images of cholangiocarcinoma associated with clonorchiasis show both the tumor with obstruction images and diffuse dilatation of the peripheral intrahepatic bile ducts. Radiological images can be a good practical alternative diagnostic method of clonorchiasis.